Skip to main content
Elaine Shum, MD, Oncology, New York, NY

Elaine Shum MD

Hematologic Oncology, Thoracic Cancer


Thoracic Oncologist at NYU Langone Perlmutter Cancer Center

Join to View Full Profile
  • 1000 10th AveNew York, NY 10019

  • Phone+1 212-523-4000

  • Fax+1 212-562-4036

Dr. Shum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2014 - 2017
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2011 - 2014
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 2011
  • Yale University
    Yale UniversityBS, Biology, 2002 - 2006

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2013 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Lung Cancer Among Asian Americans: ‘It’s Okay to Ask’
    Lung Cancer Among Asian Americans: ‘It’s Okay to Ask’November 28th, 2020
  • Astra Zeneca Panel Addresses Lung Cancer Among Asian Americans
    Astra Zeneca Panel Addresses Lung Cancer Among Asian AmericansNovember 18th, 2020
  • Xencor Presents Updated Data from the DUET-2 Phase 1 Study of XmAb20717, PD-1 X CTLA-4 Bispecific Antibody, at the SITC Annual Meeting
    Xencor Presents Updated Data from the DUET-2 Phase 1 Study of XmAb20717, PD-1 X CTLA-4 Bispecific Antibody, at the SITC Annual MeetingNovember 9th, 2020
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: